Literature DB >> 20204287

Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities.

Gregory T Langland1, Steven M Yannone, Rachel A Langland, Aki Nakao, Yinghui Guan, Sydney B T Long, Lien Vonguyen, David J Chen, Joe W Gray, Fanqing Chen.   

Abstract

The variability of radiation responses in ovarian tumors and tumor-derived cell lines is poorly understood. Since both DNA repair capacity and p53 status can significantly alter radiation sensitivity, we evaluated these factors along with radiation sensitivity in a panel of sporadic human ovarian carcinoma cell lines. We observed a gradation of radiation sensitivity among these sixteen lines, with a five-fold difference in the LD50 between the most radiosensitive and the most radioresistant cells. The DNA-dependent protein kinase (DNA-PK) is essential for the repair of radiation induced DNA double-strand breaks in human somatic cells. Therefore, we measured gene copy number, expression levels, protein abundance, genomic copy and kinase activity for DNA-PK in all of our cell lines. While there were detectable differences in DNA-PK between the cell lines, there was no clear correlation with any of these differences and radiation sensitivity. In contrast, p53 function as determined by two independent methods, correlated well with radiation sensitivity, indicating p53 mutant ovarian cancer cells are typically radioresistant relative to p53 wild-type lines. These data suggest that the activity of regulatory molecules such as p53 may be better indicators of radiation sensitivity than DNA repair enzymes such as DNA-PK in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204287      PMCID: PMC2909445          DOI: 10.3892/or_00000728

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  21 in total

1.  p53-dependent radioresistance in ovarian carcinoma cell lines.

Authors:  N Concin; C Zeillinger; M Stimpfel; I Schiebel; D Tong; U Wolff; A Reiner; S Leodolter; R Zeillinger
Journal:  Cancer Lett       Date:  2000-03-31       Impact factor: 8.679

2.  Assembly of microarrays for genome-wide measurement of DNA copy number.

Authors:  A M Snijders; N Nowak; R Segraves; S Blackwood; N Brown; J Conroy; G Hamilton; A K Hindle; B Huey; K Kimura; S Law; K Myambo; J Palmer; B Ylstra; J P Yue; J W Gray; A N Jain; D Pinkel; D G Albertson
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

3.  Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines.

Authors:  Philippe Mérel; Alexandre Prieur; Petra Pfeiffer; Olivier Delattre
Journal:  Oncogene       Date:  2002-08-15       Impact factor: 9.867

Review 4.  First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer.

Authors:  Gavin C E Stuart
Journal:  Gynecol Oncol       Date:  2003-09       Impact factor: 5.482

5.  Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas.

Authors:  G Hodgson; J H Hager; S Volik; S Hariono; M Wernick; D Moore; N Nowak; D G Albertson; D Pinkel; C Collins; D Hanahan; J W Gray
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 6.  Treatment of platinum-resistant ovarian cancer.

Authors:  E L Trimble; J Wright; M C Christian
Journal:  Expert Opin Pharmacother       Date:  2001-08       Impact factor: 3.889

Review 7.  The role of p53 in chemosensitivity and radiosensitivity.

Authors:  Wafik S El-Deiry
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

8.  The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype.

Authors:  F Dicker; H Herholz; S Schnittger; A Nakao; N Patten; L Wu; W Kern; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

9.  Expression of Ku70 correlates with survival in carcinoma of the cervix.

Authors:  C R Wilson; S E Davidson; G P Margison; S P Jackson; J H Hendry; C M West
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy.

Authors:  T Kihana; H Tsuda; S Teshima; S Okada; S Matsuura; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-09
View more
  10 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  MIIP gene expression is associated with radiosensitivity in human nasopharyngeal carcinoma cells.

Authors:  Hong-Ping Zhou; Lu-Xi Qian; Nan Zhang; Jia-Jia Gu; Kai Ding; Jing Wu; Zhi-Wei Lu; Ming-Yu Du; Hong-Ming Zhu; Jian-Zhong Wu; Xia He; Li Yin
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

3.  Radiosensitizing activity of a novel Benzoxazine through the promotion of apoptosis and inhibition of DNA repair.

Authors:  Suraj Radhamani; Christopher Bradley; Terri Meehan-Andrews; Saleh K Ihmaid; Jasim Al-Rawi
Journal:  Invest New Drugs       Date:  2014-03-14       Impact factor: 3.850

Review 4.  Ovarian cancer biomarker discovery based on genomic approaches.

Authors:  Jung-Yun Lee; Hee Seung Kim; Dong Hoon Suh; Mi-Kyung Kim; Hyun Hoon Chung; Yong-Sang Song
Journal:  J Cancer Prev       Date:  2013-12

5.  TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer.

Authors:  Xin Nie; Cong Liu; Qian Guo; Ming-Jun Zheng; Ling-Ling Gao; Xiao Li; Da-Wo Liu; Lian-Cheng Zhu; Juan-Juan Liu; Bei Lin
Journal:  Cancer Manag Res       Date:  2019-01-17       Impact factor: 3.989

6.  Mutual regulation between DNA-PKcs and Snail1 leads to increased genomic instability and aggressive tumor characteristics.

Authors:  B-J Pyun; H R Seo; H-J Lee; Y B Jin; E-J Kim; N H Kim; H S Kim; H W Nam; J I Yook; Y-S Lee
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

7.  CoMAGC: a corpus with multi-faceted annotations of gene-cancer relations.

Authors:  Hee-Jin Lee; Sang-Hyung Shim; Mi-Ryoung Song; Hyunju Lee; Jong C Park
Journal:  BMC Bioinformatics       Date:  2013-11-14       Impact factor: 3.169

Review 8.  Regulation of extracellular signal-regulated kinase 1/2 influences hippocampal neuronal survival in a rat model of diabetic cerebral ischemia.

Authors:  Yaning Zhao; Jianmin Li; Qiqun Tang; Pan Zhang; Liwei Jing; Changxiang Chen; Shuxing Li
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135

9.  High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation.

Authors:  Danielle L Bourgeois; Karl A Kabarowski; Veronica L Porubsky; Pamela K Kreeger
Journal:  Cancer Cell Int       Date:  2015-12-07       Impact factor: 5.722

Review 10.  Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy.

Authors:  Daniela A Dungl; Elaina N Maginn; Euan A Stronach
Journal:  Front Oncol       Date:  2015-10-26       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.